Drug Type Antibody drug conjugate (ADC) |
Synonyms ABT-700 (S238C)-PBD |
Target |
Action inhibitors |
Mechanism c-Met inhibitors(Hepatocyte growth factor receptor inhibitors), DNA alkylating agents |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |



| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colorectal Cancer | Preclinical | United States | 20 Apr 2026 | |
| Colorectal Cancer | Preclinical | United States | 20 Apr 2026 |






